Surgical and transcatheter left atrial appendage closure in patients with atrial fibrillation and hypertrophic cardiomyopathy
Open Access
- 5 May 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 25 (5)
Abstract
Patients with hypertrophic cardiomyopathy (HCM) and atrial fibrillation (AF) are at increased stroke risk in comparison to those with non-valvular AF not affected by HCM. To investigate the role of left atrial appendage closure (LAAC) in patients with HCM and AF. We identified patients with HCM and AF using the National Readmission Dataset. Patients were stratified based on LAAC status. The primary efficacy outcome was a composite of ischaemic and haemorrhagic stroke, TIA, and all-cause mortality. The primary safety outcome was a composite of major bleeding and pericardial complications. Patients were matched using inverse probability of treatment weighting. Cox-proportional hazard regression was applied to calculate the hazard ratio (HR) with a 95% confidence interval (CI) on matched cohorts. We identified 71 980 patients with HCM and AF. 1351 (1.9%) patients underwent LAAC. Two hundred and eighty-seven (21.2%) underwent transcatheter LAAC. LAAC was associated with a lower risk of the primary efficacy outcome (2.5% vs. 5.4%, HR: 0.38; 95% CI: 0.17–0.88; P = 0.024), the primary safety outcome (2.9% vs. 6.8%, HR: 0.39; 95% CI: 0.23–0.66, P = 0.001), and reduced major bleeding. The LAAC group trended towards a lower risk of ischaemic stroke and all-cause mortality. Surgical and transcatheter LAAC was associated with a lower risk of haemorrhagic stroke and major bleeding.Keywords
This publication has 25 references indexed in Scilit:
- EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an updateEP Europace, 2019
- The STROBE guidelinesSaudi Journal of Anaesthesia, 2019
- Estimates and Temporal Trend for US Nationwide 30-Day Hospital Readmission Among Patients With Ischemic and Hemorrhagic StrokeJAMA Network Open, 2018
- Thirty-Day Readmissions After Endovascular or Surgical Therapy for Critical Limb IschemiaCirculation, 2017
- Why Summary Comorbidity Measures Such As the Charlson Comorbidity Index and Elixhauser Score WorkMedical Care, 2015
- Prediction of Thrombo-Embolic Risk in Patients with Hypertrophic Cardiomyopathy (HCM Risk-CVA)European Journal of Heart Failure, 2015
- Atrial Fibrillation in Hypertrophic Cardiomyopathy: Prevalence, Clinical Correlations, and Mortality in a Large High‐Risk PopulationJournal of the American Heart Association, 2014
- Left atrial volume predicts adverse cardiac and cerebrovascular events in patients with hypertrophic cardiomyopathyCardiovascular Ultrasound, 2011
- Management of Cocaine-Associated Chest Pain and Myocardial InfarctionCirculation, 2008
- Impact of Atrial Fibrillation on the Clinical Course of Hypertrophic CardiomyopathyCirculation, 2001